Replies to post #14887 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Thanks Slivr, as I read it it looks like ANIP could own 18.7 % of a $2 billion company. I agree I can see investor led litigation landing on CG Oncology's doorstep.

Regarding them hanging their hat on patent expiration. I found Beyond Hybrid Licenses—Strategies for Post Patent Expiration Payments in the United States very interesting in understanding the possible arguments and case law impacting those arguments.

When looking at the B. Kimble v. Marvel Entertainment, LLC case, if they remain consistent, it appears that, Justices Alito, Thomas and Roberts would likely side with ANIP if it ever got to the supreme court.